The FDA, CDC and CMS want to speed access to diagnostic tools during public health emergencies, such as an infectious disease outbreak.
The FDA will authorize emergency use of tests, the CDC will provide lab and epidemiology expertise, and CMS will ensure that labs produce accurate and timely results.
Before an emergency, the task force will identify gaps in protocols by reviewing recent emergency response experiences and current practices.
The task force will meet twice yearly.
More articles on clinical leadership and infection control:
WHO issues urgent call for more Ebola funding
State-mandated reporting laws may lower time spent on infection control activities, survey finds
SHEA names permanent executive director
